Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.
about
The gut-adipose-liver axis in the metabolic syndromeA potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseasesDeletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generationUpregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosisAldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages.Glutathionylated products of lipid peroxidation: A novel mechanism of adipocyte to macrophage signalingALDOSE REDUCTASE: New Insights for an Old Enzyme.Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis ratsAnti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.Aldose reductase mediates retinal microglia activation.Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity.Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsisGlutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation.Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model.AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy.Development of aldose reductase inhibitors for the treatment of inflammatory disorders.Aldose reductase participates in the downregulation of T cell functions due to suppressor macrophages.Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages.Proteomic analysis of the anti-inflammatory action of minocycline.Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages.Efficacy of structurally diverse aldose reductase inhibitors on experimental periodontitis in rats.Inhibition of aldose reductase attenuates endotoxin signals in human non-pigmented ciliary epithelial cells.Evaluation of a selected lactic acid bacteria-based probiotic on Salmonella enterica serovar Enteritidis colonization and intestinal permeability in broiler chickens.Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues.Effect of an aldose reductase inhibitor on alveolar bone loss associated with periodontitis in diabetic rats.Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
P2860
Q26995575-45C1B708-0561-4FD1-A6BB-D6CD04F08490Q28382891-F517EC56-4127-4D4F-A9E1-261B55BE95C1Q28486203-DAD0940B-40D6-4473-9865-D72451F851A1Q30440695-F2894EEE-F0BC-4865-93D1-9868A80DBFE0Q33567452-C05FAE19-5413-43A6-83D7-4A6A58C025B7Q33823182-58E1A0E4-D8BC-450E-B349-AF79FA674ADDQ33946414-3B99A53C-714D-4539-BE44-4FBFCE85719DQ34895688-CADF88AE-5C89-46A0-A992-70F879E7673EQ35281290-23420168-60CF-4976-B29B-C8C9EE7B9EC5Q35522151-C1B5016A-D9A8-4D10-AEFD-8B7B89F9242BQ35645348-2B349116-20AB-4D1B-B679-12B9334BB5C7Q36813604-81C37B7A-07DB-4444-83C1-397DB679D5A4Q36818172-07E6D792-2A3E-465D-8B1C-4FAC8E7F6B57Q37399788-3F7DC04C-8E0A-4392-9B45-0341AD0E16E0Q37403301-BCFB4BD9-100B-42CE-8CE6-477B4602F83DQ37414643-FB59417A-D5DE-4B29-9339-4CAC51A9F5A4Q37509810-0F7CC07E-0A2B-41C4-926F-9BE8D97DC5C1Q37601128-E3DE3CC2-825D-4898-B7A0-46A668211B3BQ38148786-20BCD52F-9F8F-46B1-9AF4-B3871022D22EQ38381878-D2B5E28E-D248-4998-B1A6-0C19C1782372Q39006771-23C07BB6-480A-4875-BD30-4B2F5FF6D072Q39616576-F23F5753-D47F-4435-9B2A-23A7028C0905Q39729433-5037A9CF-33FB-4382-90C2-D216201C2E66Q39964588-18424BD3-293E-4618-AF2F-043C4308B53DQ40010526-05EBFDB6-0162-40EF-A69F-8DD87C4A861AQ40568632-A54399C5-506E-4F9B-B93A-73D1B26C9273Q40792033-D4C95A34-CD14-4980-902D-011658B34749Q42171330-372845C9-4104-4378-A168-D757BCF77762Q47446145-7008E782-B348-4478-BD0E-80C702F13FF8
P2860
Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mediation of aldose reductase ...... mouse peritoneal macrophages.
@en
type
label
Mediation of aldose reductase ...... mouse peritoneal macrophages.
@en
prefLabel
Mediation of aldose reductase ...... mouse peritoneal macrophages.
@en
P2860
P1433
P1476
Mediation of aldose reductase ...... mouse peritoneal macrophages.
@en
P2093
Satish K Srivastava
P2860
P304
P356
10.1016/J.CYTO.2006.11.003
P577
2006-11-01T00:00:00Z